Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

O&G VivasGynaecological health — androgen excess

O&G Vivas · Gynaecological health — androgen excess

Hirsutism and virilisation — structured oral station (12 minutes)

FRANZCOG oral-format station on hirsutism and virilisation: the candidate scores the mFG, justifies the androgen panel with the LC-MS/MS requirement, walks the Endocrine Society 2018 management ladder with the contraceptive rule, and recognises the tumour-threshold red flag. Scored against the eight published RANZCOG oral domains.

clinical3 min readVerification in progress

Target exams

FRANZCOGMRCOGABOG
On this page
Study tools

Target exams

FRANZCOGMRCOGABOG
Prompt
You are the gynaecology registrar in clinic. A 24-year-old woman presents with a 3-year history of gradually worsening coarse hair on her chin, chest and lower abdomen. Her cycles are regular (every 28 days). Her mFG score is 11. The examiner will ask you to score the hair, defend the investigation panel, reproduce the Endocrine Society 2018 management ladder, and recognise the red flags that demand tumour imaging. You may be shown a body diagram of the nine modified Ferriman-Gallwey sites.

Station format

4 minutes reading, 12 minutes examination, 20 marks, global scoring. The eight published RANZCOG oral domains apply to every station: history and examination; investigations and interpreting results; treatment/management; clinical knowledge; complex, urgent or unusual clinical presentations; rapport with patient, support person or colleague; respect; communication skills. You are marked on how you behave, not only what you know. [1]

Reveal the examiner script and model responsesShowHide

Opening prompt — "Score this woman's hair. What is the mFG and what threshold defines hirsutism?"

Model response — the mFG verbatim: [2][3]

  • "The modified Ferriman-Gallwey score grades nine androgen-sensitive body sites — upper lip, chin, chest, upper back, lower back, upper abdomen, lower abdomen, upper arms and thighs — each from 0 to 4, for a maximum of 36. She scores 11, which exceeds the Caucasian threshold of 8 and meets the definition of hirsutism."
  • "I would note that the threshold is ethnicity-specific — over 6 for Mediterranean, over 4 to 5 for South Asian and African, over 2 to 3 for East Asian women — because baseline terminal hair varies between populations."[2][3]

Probe 1 — "What investigations will you order?"

  • "The androgen panel: total testosterone, SHBG and the calculated free androgen index — the most sensitive biochemical marker — DHEAS, 17-hydroxyprogesterone, androstenedione, plus prolactin and TSH in every workup. I insist on an LC-MS/MS assay, because direct immunoassays overestimate testosterone in the low female range."[1]
  • "The single most important rule-out is a morning 17-hydroxyprogesterone, drawn day 3 to 5, fasting, to exclude non-classic congenital adrenal hyperplasia. A baseline over 6 nmol/L is confirmed by an ACTH stimulation test with a peak over 30 to 65 nmol/L."[4]

Probe 2 — "Her 17-OHP is normal, testosterone is mildly elevated, cycles regular. What is your management?"

  • "I follow the Endocrine Society 2018 ladder. Cosmetic measures first — shaving, waxing, bleaching — begin immediately. Then a combined oral contraceptive pill, choosing one with an anti-androgenic progestogen like drospirenone or cyproterone. I allow 6 months to judge the response before escalating."[1]
  • "If response is suboptimal at 6 months, I add an anti-androgen — spironolactone 100 to 200 mg a day is first-line. And I add laser or photoepilation for those who want additional cosmetic benefit, plus eflornithine 13.9 percent cream as a topical adjunct."[5]

Probe 3 — "She is sexually active and uses no contraception. Can you prescribe spironolactone?"

  • "No — not without reliable contraception. The Endocrine Society recommends against anti-androgen monotherapy unless adequate contraception is used, because spironolactone, cyproterone and finasteride are teratogenic and feminise a male fetus. I would start the combined oral contraceptive pill first, which both provides contraception and is first-line pharmacotherapy. Spironolactone can be added after 6 months."[1]

Probe 4 — "Does metformin have a role for her hirsutism?"

  • "No. The Endocrine Society 2018 guideline recommends against insulin-lowering drugs for hirsutism alone — they are not effective for this indication. Metformin has a role in PCOS for impaired glucose tolerance or as an adjunct to fertility therapy, but not for hirsutism."[1]

Probe 5 — "A different patient, 38, has 4 months of progressive hirsutism with clitoromegaly and voice deepening, and a total testosterone of 9 nmol/L. What changes?"

  • "Everything changes. This is virilisation with rapid tempo and a testosterone of 9 nmol/L — well above the 5 nmol/L threshold that mandates imaging for an androgen-secreting tumour. The next step is urgent pelvic ultrasound first for an ovarian source, then adrenal CT or MRI, and urgent surgical referral. I do not start a COCP or anti-androgen before excluding the tumour."[1]

Probe 6 — "She is distressed about her appearance and has stopped socialising. What do you say?"

This is a scored communication domain — demonstrate it out loud: [1]

  • Move to her eye level, use her name, acknowledge the distress: "Excess hair is a real and distressing symptom, and it is not vanity to want it treated. We have a clear evidence-based ladder — the pill, anti-androgens, laser — and most women see a meaningful improvement within 6 months. The hair cycle sets the timeline, so I will not promise overnight results, but I will promise we will work through the options together. You are not coping with this alone."[1]
Obstetrics & Gynaecology Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH, Pugeat MM, Rosenfield RL. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2018.PMID 29522147
  2. [2]Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring hirsutism. Hum Reprod Update, 2010.PMID 19567450
  3. [3]Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol, 1981.PMID 7258262
  4. [4]Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2010.PMID 20823466
  5. [5]Alesi S, Forslund M, Melin J, et al. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. EClinicalMedicine, 2023.PMID 37583655
Obstetrics & Gynaecology Pro

$29/ monthor $279 / year

The complete Obstetrics & Gynaecology library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousHereditary gynaecological cancer syndromes — structured oral station (12 minutes)Gynae-oncology — hereditary cancerNextHuman factors, teamwork and leadership on labour ward — structured oral station (12 minutes)Professional practice — patient safety and systems